famotidine has been researched along with Critical Illness in 9 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of famotidine on gastroesophageal reflux (GER) and duodeno-gastro-esophageal reflux (DGER) and to explore it's possible mechanisms." | 7.72 | The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal refluxes in critically ill patients. ( Dai, N; Si, JM; Wang, JG; Xin, Y; Zhao, L, 2003) |
| "To characterize and compare acid suppression (pharmacodynamics) and pharmacokinetics of IV famotidine and ranitidine in critically ill children at risk for stress gastritis." | 5.19 | Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children. ( Kauffman, R; Lai, ML; Lehr, VT; Madani, S; Sarniak, A; Simpson, P; Tolia, V, 2014) |
| "To investigate the effect of famotidine on gastroesophageal reflux (GER) and duodeno-gastro-esophageal reflux (DGER) and to explore it's possible mechanisms." | 3.72 | The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal refluxes in critically ill patients. ( Dai, N; Si, JM; Wang, JG; Xin, Y; Zhao, L, 2003) |
| " Data on patient demographics, drug administration time, adverse effects, cardiovascular variables, and costs (including drug acquisition, supply, and nursing personnel costs) were collected prospectively." | 2.68 | Safety and cost of rapid i.v. injection of famotidine in critically ill patients. ( Fish, DN, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, YH | 1 |
| Cai, WK | 1 |
| Yin, SJ | 1 |
| Wang, P | 1 |
| Li, ZR | 1 |
| Yang, Q | 1 |
| Zhou, T | 1 |
| Meng, R | 1 |
| Yang, M | 1 |
| Guo, Y | 1 |
| He, GH | 1 |
| Madani, S | 1 |
| Kauffman, R | 1 |
| Simpson, P | 1 |
| Lehr, VT | 1 |
| Lai, ML | 1 |
| Sarniak, A | 1 |
| Tolia, V | 1 |
| Lwin, AA | 1 |
| Brophy, GM | 1 |
| Brackbill, ML | 1 |
| Bidwell, KL | 1 |
| Brophy, DF | 1 |
| Xin, Y | 1 |
| Dai, N | 1 |
| Zhao, L | 1 |
| Wang, JG | 1 |
| Si, JM | 1 |
| Baghaie, AA | 1 |
| Mojtahedzadeh, M | 1 |
| Levine, RL | 1 |
| Fromm, RE | 1 |
| Guntupalli, KK | 1 |
| Opekun, AR | 1 |
| Wilson, P | 1 |
| Clark, GW | 1 |
| Anselmino, M | 1 |
| Welch, NT | 1 |
| Singh, S | 1 |
| Perdikis, G | 1 |
| Hinder, RA | 1 |
| Fish, DN | 1 |
| Aanpreung, P | 1 |
| Vanprapar, N | 1 |
| Susiva, C | 1 |
| Parkpreaw, C | 1 |
| Boonyachart, C | 1 |
6 trials available for famotidine and Critical Illness
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Topics: Child; Child, Preschool; Critical Illness; Famotidine; Female; Gastric Acid; Gastric Acidity Determi | 2014 |
Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Critical Illness; Famotidine; Fem | 2010 |
Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
Topics: Adult; Aged; Critical Illness; Cross-Over Studies; Famotidine; Female; Gastric Acid; Humans; Hydroge | 1995 |
Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients.
Topics: Adult; Aluminum Hydroxide; Antacids; Critical Illness; Drug Combinations; Famotidine; Female; Gastri | 1993 |
Safety and cost of rapid i.v. injection of famotidine in critically ill patients.
Topics: Costs and Cost Analysis; Critical Illness; Famotidine; Humans; Infusions, Intravenous; Injections, I | 1995 |
A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
Topics: Analysis of Variance; Child; Child, Preschool; Critical Illness; Famotidine; Female; Gastrointestina | 1998 |
3 other studies available for famotidine and Critical Illness
| Article | Year |
|---|---|
Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study.
Topics: Cohort Studies; Critical Illness; Famotidine; Heart Failure; Histamine H2 Antagonists; Humans; Ranit | 2022 |
Famotidine versus pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Critical Illness; Famotidine; Histamine H2 Antagonists; Hum | 2008 |
The effect of famotidine on gastroesophageal and duodeno-gastro-esophageal refluxes in critically ill patients.
Topics: Adult; Aged; Bile Reflux; Critical Illness; Famotidine; Female; Gastric Acid; Gastroesophageal Reflu | 2003 |